Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0000899243-17-028955

Glass John R bought 200,000 shares at an average $0.05 ($10,792)

From the SEC's structured data for this filing

Trades in this filing

Glass John R

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-12-14 Purchase : show line 1 in the form +84,100 $0.05 $4,533 84,100 D
2017-12-14 Purchase : show line 2 in the form +115,900 $0.05 $6,259 200,000 D
Open-market purchases · 200,000 sh · avg $0.05 · $10,792
Loading xslF345X03/doc4.xml…